Metabolic response to injury
The response to trauma is well described in animal models and classically is divided into two phases, the`ebb' phase and the`¯ow' phase (Frayn, 1986) . The so called`ebb' phase corresponds to the period of`shock', and is characterised by a reduction in spontaneous and metabolic activity and body temperature and merges over several hours into the`¯ow' phase. This is a period of regeneration and repair; it is associated with an increase in metabolic activity, body temperature and metabolic rate. Appetite is depressed, the organism survives at least in part off its own endogenous energy stores and there is a loss of body mass, particularly lean body mass (Frayn, 1986) . It is uncertain whether a true`ebb' phase in man actually exists but measurements made during resuscitation have indicated that a proportion of patients who respond to resuscitation with a rise in energy expenditure (oxygen consumption), as a group, have a better outcome than those who do not (Tuschmidt et al, 1989) .
Substrate mobilisation
The metabolic stress response elicited by trauma is characterised by an immediate mobilisation of endogenous substrate, glucose, free fatty acids etc, at rates exceeding the patient's ability to use them. Therefore immediate increases in blood concentrations of glucose and free fatty acids occur and insulin secretion is inhibited. Substrate mobilisation may even start before the injury itself, set in motion by visual and emotional stimuli. It is mediated in part by the various counterregulatory hormones, for example, catecholamines, glucagon, cortisol and the cytokines (Frayn, 1986) .
Wound tissue meets its energy needs from glycolysis, lactate passing to the liver to be resynthesised into glucose; glucose requirements for the brain and blood cells remain unchanged. There is therefore an increased need for glucose and this is met by gluconeogenesis with a breakdown of lean (protein) tissue and a rise in urinary nitrogen excretion. This comes ultimately from muscle and there is a loss of muscle mass. Any loss of body protein is inevitably accompanied by a decline in function (Hill, 1992a) . In the well nourished, energy expenditure is elevated in proportion to the severity of the injury, although the decline in food intake tends to offset this, and combined with enforced immobility a rise in energy expenditure may not always be evident.
The nature of the response is remarkably uniform regardless of the cause. The response to infection and sepsis is similar to trauma but is more variable and in many instances it may be impossible to say precisely at what point it starts. Following uncomplicated injury the amount of protein lost is well de®ned depending on the size of the injury. After an elective major abdominal operation for example, which is usually associated with an acute decline and even an absence of food intake for several days, 5% of total body protein is lost, then regained to preoperative values over three months (Hill, 1992b) .
Multiple organ dysfunction and multiple organ failure (MOF) who initially do well, but then various organ systems start to fail (Baue, 1991) . Instead of recovering in a predictable fashion with a move into the anabolic phase there is an apparent persistence of the`¯ow' phase often alternating with periods of shock. The respiratory system is usually the ®rst to fail with areas of alveolar exudate, stiff lungs and ultimately ventilatory failure, associated frequently with decreased peripheral resistance and depressed myocardial function. Arti®cial ventilatory support is instituted and the cardiovascular system is supported with inotropes and vasopressors. Failure of gastrointestinal function, absorption and motility (Johnston et al, 1996) , necessitates the use of arti®cial nutritional support, parenteral or enteral, and if renal failure supervenes renal replacement therapy such as haemo®ltration or haemodialysis is required. Rates of urinary nitrogen excretion in MOF are in the region of 20 ga24 h (Streat et al, 1987; Finn et al, 1996; Clark et al, 1996) .
Although the picture, metabolically and clinically, is similar to a patient in the`¯ow' phase of severe injury, or suffering from severe sepsis, often no septic or infectious focus can be found, even at post-mortem (Deitch, 1993) . The realisation that one could be`septic' without necessarily being infected has received of®cial recognition only relatively recently when, in a consensus paper in 1992, a condition termed the`systemic in¯ammatory reaction syndrome' (SIRS) was de®ned in terms of the generalised cardiovascular, respiratory and temperature responses to a pathological insult, for example, traumatic, septic or thermal (American College, 1992) .
The picture is similar also to that seen in severe burn injury where the in¯ammatory response persists for the time it takes for the burn wound to heal. However unlike an uncomplicated burn, or other discrete injury, the course of multiple organ failure or dysfunction is not predictable and the patient's condition often changes unexpectedly, for the better or for the worse . Periods of hypotension and hypovolaemia are seen, often for no obvious clinical reason but requiring resuscitation with intravenous¯uids, and these¯uids are subsequently retained. Fluid retention of 5 ± 15 L is common and ®gures in excess of 35 L have been reported (Streat et al, 1987; Hall et al, 1992; Lucas & Ledgerwood, 1983) .
The nature of the ongoing in¯ammatory stimulus As stated above, the site and the cause of the ongoing in¯ammatory stimulus that is assumed to drive this response may not be identi®ed, even at post-mortem. Attention over the last 10 y has centred on the gastrointestinal tract. Following an acute episode of injury, shock or sepsisainfection the wall of the gut is said to become permeable; bacteria and endotoxin leak into the portal and systemic circulations and set up a generalised in¯am-matory reaction with release of the various cytokines and in¯ammatory mediators (Marshall et al, 1993) . These include tumour necrosis factor, interleukin-1 and interleukin-6 etc. The macrophages in the liver (Kupffer Cells) are thought to be particularly important in this respect (Lowry, 1990) .
There is a lot of evidence from animal work that early enteral feeding after an injury reduces the severity of the in¯ammatory response by maintaining the integrity of the gastrointestinal tract. The evidence that the same bene®ts apply in man is less convincing, although early enteral feeding after surgery for major abdominal trauma has been shown to be associated with a lower incidence of septic complications compared with patients treated conventionally (Moore & Jones, 1986 ) (initially nil by mouth) or fed parenterally (Moore et al, 1989) . Evidence is also accumulating from some studies (Carr et al, 1966; Beier-Holgersen & Boesby, 1996) , but not all (Reynolds et al, 1997) , that early enteral feeding after elective abdominal surgery may be associated with a lower incidence of postoperative complications compared with the conventional management of allowing a normal intake to be resumed spontaneously.
Recent evidence has indicated there may also be a genetic pre-disposition to the severity of the in¯ammatory response that an individual mounts. Stuber et al (1996) demonstrated that severely septic (and infected) individuals who were homozygous for the TNFB 2 gene had higher circulating TNF alpha levels than those who were homozygous for the TNFB 1 gene, or heterozygous (TNFB 1 aTNFB 2 ), and had a higher mortality.
Arti®cial feeding and the in¯ammatory response
When an acutely ill patient is unable to eat, arti®cial nutritional support is provided, either enterally or parenterally. Enteral feeding is the preferred route, partly for the reasons outlined above, but also because it is more physiological and less expensive than parenteral nutrition. In established MOF however it is probably too late for enteral feeding to make any difference to outcome.
If the patient is well nourished and is likely to resume oral intake within 7 ± 10 d intravenous nutritional support is not normally provided as the mortality and morbidity associated with the provision of arti®cial feeding in this group is greater than the bene®ts that ensue (Veterans Affairs, 1991) . In terms of maintaining or, more rarely, increasing lean body mass, markedly depleted patients have been shown to bene®t more from arti®cial feeding than the relatively well nourished (Hill et al, 1991) .
Assessment of energy requirements
With uncomplicated trauma energy expenditure can be assessed clinically and, as stated earlier, is dependent on the severity of the injury (Wilmore, 1977) . In multiple organ failure there is no relationship between severity of illness and energy expenditure, so energy expenditure cannot reliably be predicted and has to be measured using indirect calorimetry (Brandi et al, 1997) . There are problems with indirect calorimetry in ventilated patients: one is their need for a high concentration of inspired oxygen to maintain arterial oxygenation; the other is the high humidity required in breathing circuits. The theoretical basis of the problem with a high inspired oxygen concentration is well described by Ultman & Berzstein (1981) and is basically the problem of the oxygen sensors differentiating between the inspired (F I O 2 ) and expired gas concentrations against the background of an increasingly high oxygen signal, until at an inspired oxygen concentration of 100% it becomes impossible.
The high humidity problem has been solved by sampling the inspired and expired gas concentrations using tubing which is highly permeable to water vapour (Regan et al, 1990) . Because of the problem with the high F I O 2 all the commercially available indirect calorimeters cease to give Limitations of nutrient intake IT Campbell reliable results at an F I O 2 much above 0.6 ± 0.7. There are a number of ways around this problem, such as measuring inspired and expired volumes separately (Svensson et al, 1990) , although this is technically very dif®cult to do with a suf®cient degree of accuracy, or measuring VCO 2 and assuming a respiratory quotient; oxygen consumption and energy expenditure can then be calculated. Technically this is the simplest solution; it introduces an error, but this is unlikely to exceed 10% and is certainly better than not making the measurement at all. Although it is the simplest solution, no manufacturer so far appears to have taken it up, despite the fact that at present the standard method of measuring energy expenditure in the free living individual is to measure carbon dioxide production and assume an RQ, or derive one from the food intake (Coward, 1988) . Measurements of energy expenditure in ventilated patients with MOF have consistently shown a very wide range of values from 50 ± 200% of the basal value, predicted from age, height and weight, with an average of around 120 ± 140% Mann et al, 1985; Weissman et al, 1986; Swinamer et al, 1987) . It has to be borne in mind that such measurements are markedly affected by the varying degrees of sedation and muscle relaxation required to facilitate arti®cial ventilation.
The delivery of nutritional support in the critically ill
There are problems with providing nutritional support to an acutely ill individual overloaded with¯uid. High levels of sympathetic activity impair gastric emptying so enteral feeding may have to be given beyond the pylorus (Johnston et al, 1996) , a technique that carries risks and may limit the quantities that can be given. Because of impaired gastrointestinal function it may not be possible to provide all the needed nutrients enterally (Kemper et al, 1992) . In addition the¯uid retention referred to earlier can cause problems with parenteral feeding and this may have to be limited because of the dangers of¯uid overload on lung function and gas exchange . Increasingly however, as experience is gained with haemo®ltration, excess uid is being actively removed in order to allow adequate nutrient support (Rodriguez et al, 1992; Bellomo et al, 1991) .
Body mass and composition in MOF
Fluid retention complicates the assessment of body composition as almost all the conventional methods, for example, body weight, skinfolds and impedance etc., assume a normal state of hydration. The only really satisfactory technique is neutron activation analysis, but that involves signi®cant amounts of radiation and is not widely available. In New Zealand a facility has been built for use in critically ill patients (Beddoe et al, 1984) .
The classic work on nutritional support in multiple organ failureadysfunctionasevere sepsis is that of Streat and colleagues published in 1987 (Streat et al, 1987) . They fed, intravenously, a group of patients with severe sepsis at a rate corresponding to 2400 kcals and 20 g of nitrogena24 h for a 70 kg adult, 20% fat. They did not measure energy expenditure, but over 10 d their subjects lost 12.5% of their total body protein as assessed by neutron activation analysis, and body fat increased. The same group have reproduced these results on at least two other occasions since (Finn et al, 1996; Clark et al, 1996) .
Others have measured changes in arm circumference which, although confounded by¯uid retention, is easy to do. Changes in muscle ®bre area have been measured microscopically from muscle biopsies Helliwell et al, 1991; Grif®ths et al, 1995) . This is invasive however and liable to complications; also the conclusions drawn can obviously only apply to the particular muscle being biopsied, but rates of muscle wasting of 5%ad have been described Helliwell et al, 1991; Grif®ths et al, 1995) . Similar ®gures were obtained using an ultrasound technique developed to monitor muscle wasting in the presence of oedema , but these latter results have yet to be con®rmed. Measuring arm circumference and muscle ®bre area demonstrated that lean body mass was lost regardless of energy balance, patients apparently adequately fed wasting at the same rate as those fed less energy than their measured requirement. These results have since been con®rmed by others, but using slightly different methods (Frankenfeld et al, 1997) .
Metabolic aspects of nutritional support in MOF
The fundamental problem in all of this is the ongoing gluconeogenesis. Shaw et al (1986) showed that in the seriously septic individual rates of hepatic glucose production were twice those of the normal individual, but whereas in normal controls glucose infused at 4 mgakgamin suppressed glucose production almost completely, in the septic patients glucose production was suppressed by only 50% and gluconeogenesis persisted, albeit at a reduced rate.
We (Arnold et al, 1993) have shown that in MOF rates of protein turnover, for example, synthesis, breakdown and oxidation, are elevated, a situation similar to that seen in severe sepsis (Shaw et al, 1987) . The precise balance of protein synthesis and breakdown depends on the severity of the injury. After a relatively minor and controlled injury such as elective surgery negative nitrogen balance is due to a depression of protein synthesis (Clague et al, 1983; Rennie, 1985) , protein breakdown remaining more or less unchanged. With severe sepsis or injury both protein synthesis and degradation are elevated, and feeding increases them still further. Shaw et al (1987) showed that feeding protein (amino acids) to patients with severe sepsis at a rate of 1.1 gakga24 h reduced net protein catabolism. Increasing the intake to 1.6 gakga24 h decreased catabolism further, but at an intake of 2.2 gakga24 h net catabolism increased again. In burned children increasing the dietary protein intake did not affect muscle protein synthesis, although it did have a bene®cial effect on skin protein synthesis (Patterson et al, 1997) .
Exogenous protein stimulates protein turnover; this raises metabolic rate, body temperature and CO 2 production. In an individual already stressed metabolically and with impaired gas exchange this is obviously undesirable. There would appear to be little point in increasing protein intake in the septic and injured, probably much beyond 1.5 gakgamin. The provision of energy (glucose) does not prevent gluconeogenesis and negative nitrogen balance and provision of protein beyond a certain point merely stimulates the process further. It appears that the best one can hope to achieve by feeding the critically ill is to attenuate the rate of loss of lean tissue.
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Streat's patients who lost 12.5% of their total body protein over 10 d, despite aggressive nutritional support (Streat et al, 1987) , increased their body fat. Fatty acids are normally metabolised in proportion to their availability. Glucose metabolism is under the control of insulin. In trauma and sepsis insulin secretion is normally inhibited and free fatty acids mobilised from adipose tissue secondary to an increase in sympatho-adrenal activity. The drive to substrate oxidation of healthy tissue is thus switched towards fat metabolism, which seems logical as the body does have larger stores of triglyceride in the form of adipose tissue than it does of any other energy substrate. This would diminish the demand for glucose which, once the glycogen stores have run out, ultimately comes from lean tissue. The fact that the critically ill can obviously store lipid, and when intravenous lipid is given it is usually cleared from the circulation very rapidly, implies that triglyceride administered for nutritional support is probably taken up by, and contributes to maintenance of, peripheral adipose tissue stores.
The septic and injured individual is thus relatively insulin resistant, a fact known from experience by any clinician who has attempted to feed such patients. Using the hyperinsulinaemic glucose clamp technique over 3 h we showed that this resistance appears to be an impairment of the ability to store glucose rather than to oxidise it (Green et al, 1955) . With glucose infused at rates designed to maintain blood glucose at 12 mmolaL plasma insulin values rose continuously in the normal controls as did rates of glucose utilisation, assumed to be secondary to the increased insulin. In the patients with MOF plasma insulin concentrations rose to only half the values seen in the controls, and exogenous glucose utilisation over the three hours did not change. Glucose oxidation increased, as denoted by a rise in respiratory exchange ratio (quotient) in both the controls and the patients and by the same amount, although at the end of the three hours when the clamp was stopped glucose oxidation rates were still between only 2 and 2.5 mgakgamin.
Non-oxidative disposal of glucose in the patients, which is presumed to represent glucose storage, declined signi®-cantly. There are two possible explanations for this. One is that there is an impairment of glucose storage: muscle biopsies from these patients showed muscle glycogen values at the lower end of but not generally outside the normal range (Campbell et al, 1999 ). An alternative explanation could be that the exogenous glucose utilisation rates were impaired by the persistence of gluconeogenesis and the ongoing hepatic glucose output.
Glycerol and free fatty acid concentrations in the two groups were depressed over the ®rst hour then¯attened out to new, lower stable concentrations, but the levels seen in the patients were still signi®cantly higher than in the controls, presumably due to an ongoing sympathetic drive stimulating lipolysis. One wonders what would have happened had the clamp continued. One can postulate that the rates of glucose oxidation in the two groups would have diverged, rates of glucose oxidation in the patients being the lower, possibly secondary to the persistent elevation in, and consequent oxidation of, free fatty acids. We have demonstrated that this depression of exogenous glucose utilisation rates can be abolished with a combination of a somatostatin analogue and replacement insulin given at a basal rate of 2 unitsah (Arnold et al, 1995) . The obvious explanation for this would be an inhibition of gluconeogenesis by the somatostatin.
Pharmacological manipulation of nutritional support
It is clear from the foregoing that in the severely septic and injured patient an improvement of nutritional status or increase of lean body mass by nutritional support alone is likely to be impossible. The most one can hope for is to slow the rate of decline. If lean body mass is to be maintained it is likely that pharmacological methods will have to be found for doing so. A number of compounds have been under investigation over the past 10 y and in general have been found to improve nitrogen balance, although they all have their problems (Jolliet & Pichard, 1997) . They include growth hormone (Jolliet & Pichard, 1997; Jeevanandam et al, 1996) , insulin like growth factor-1 (Yarwood et al, 1997) , branch chain amino acids (Garciade-Lorenzo et al, 1997), glutamine (Grif®ths et al, 1997) and insulin (Sakurai et al, 1995) . Grif®ths et al (1997) have recently shown a lower six month mortality following critical illness when the patients were given 25 g of glutamineaday as part of their parenteral nutritional support, although no measurements were made of wasting or body composition. Mechanical methods may also have a future as the same group have demonstrated that passive exercise of the leg maintains muscle ®bre area measured microscopically (Grif®ths et al, 1995) .
It is by no means certain that maintaining lean body mass in the critically ill affects mortality. Intuitively however loss of lean body mass at 1%ad (Streat et al, 1987) or muscle mass at 5%ad (Grif®ths et al, 1995) cannot be a good thing. Maintenance of muscle at the very least must surely facilitate rehabilitation. If nothing else it would ensure an adequate reservoir of gluconeogenic precursors for the liver to make glucose until such time as the illness and the in¯ammatory process had run their course.
